Events

SAN DIEGO, October 1, 2022 – Meet Antonius Schuh, Ph.D. (CEO), and Andreas Klostermann, Ph.D. (CSO) for an update on selectION’s best-in-class ion channel blockers and the status of the…

SAN DIEGO, January 11, 2022 – Meet Antonius Schuh, Ph.D. (CEO), Andreas Klostermann, Ph.D. (CSO) and Steve Zaniboni (CFO) for an update on selectION’s best-in-class ion channel blockers and the…

SAN DIEGO, January 10, 2021 – Meet Antonius Schuh, Ph.D. (CEO) and Andreas Klostermann, Ph.D. (CSO) for an update on selectION’s best-in-class ion channel blockers and the status of the…

SAN DIEGO, January 9, 2020 – Meet Antonius Schuh, Ph.D. (CEO) and Andreas Klostermann, Ph.D. (CSO) for an update on selectION’s best-in-class ion channel blockers and the status of the…

Andreas Klosterman, Ph.D. (CEO) will give an update on selectION’s best-in-class ion channel antagonists and discuss the principles of the company’s systematical peptide design to obtain the most selective and specific ion channel blockers.